A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

The buzz at this year's annual meeting of the American Academy of Ophthalmology focused on two things: the presbyopia-correcting intraocular lens market, and the controversy surrounding the drugs Lucentis and Avastin for treating wet age-related macular degeneration.

Patient safety dominated the discussions at the 2007 annual meeting of the American Society of Anesthesiologists. Although medtech manufacturers have long focused on improving safety, that movement is being further fueled by a growing number of performance measures and documentation requirements. In addition, pay-for-performance initiatives are gaining in popularity as health care buyers seek ways to drive quality improvements, putting more pressure on hospitals and physicians to provide and document quality care in order to maximize their reimbursements.

Brief summaries of recent product and company developments in the device industry, including: developments in continuous glucose monitoring, new liability conerns for device companies, medtech acquisitions in 2007, and the 2008 IPO market.